RTW Investments LP decreased its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 2.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,569,687 shares of the company's stock after selling 76,016 shares during the quarter. Establishment Labs accounts for approximately 1.8% of RTW Investments LP's holdings, making the stock its 23rd biggest position. RTW Investments LP owned approximately 9.18% of Establishment Labs worth $118,385,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Quarry LP bought a new position in shares of Establishment Labs in the 4th quarter worth approximately $27,000. R Squared Ltd bought a new stake in shares of Establishment Labs during the 4th quarter valued at $36,000. KLP Kapitalforvaltning AS bought a new stake in shares of Establishment Labs during the 4th quarter valued at $161,000. Hood River Capital Management LLC lifted its stake in shares of Establishment Labs by 236.4% during the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock valued at $273,000 after buying an additional 4,160 shares in the last quarter. Finally, Handelsbanken Fonder AB boosted its holdings in Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after buying an additional 2,000 shares during the period. 72.91% of the stock is owned by hedge funds and other institutional investors.
Establishment Labs Price Performance
Shares of NASDAQ:ESTA traded down $1.61 during mid-day trading on Wednesday, reaching $36.05. The stock had a trading volume of 74,406 shares, compared to its average volume of 469,136. The business's 50 day moving average price is $34.44 and its 200 day moving average price is $38.11. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $58.00. The company has a market cap of $1.04 billion, a P/E ratio of -14.05 and a beta of 0.73. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94.
Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.83) by $0.13. The business had revenue of $41.38 million for the quarter, compared to analysts' expectations of $41.15 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The company's revenue for the quarter was up 11.3% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.58) EPS. Research analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.
Analyst Ratings Changes
ESTA has been the topic of a number of recent analyst reports. BTIG Research initiated coverage on Establishment Labs in a report on Friday, May 16th. They set a "buy" rating and a $62.00 price target on the stock. Stephens reiterated an "overweight" rating and set a $52.00 target price on shares of Establishment Labs in a research report on Thursday, March 6th. Finally, Needham & Company LLC raised Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price target on the stock in a report on Wednesday, May 14th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $55.33.
View Our Latest Stock Analysis on ESTA
Establishment Labs Company Profile
(
Free Report)
Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
Featured Articles
Before you consider Establishment Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.
While Establishment Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
